Literature DB >> 10753708

CXCR4 mediates entry and productive infection of syncytia-inducing (X4) HIV-1 strains in primary macrophages.

A Valentin1, H Trivedi, W Lu, L G Kostrikis, G N Pavlakis.   

Abstract

CCR5 and CXCR4 are the main coreceptors for non-syncytia-inducing (NSI) and syncytia-inducing (SI) HIV-1 strains, respectively. NSI HIV-1 isolates do not infect either human lymphoid or monocytoid cell lines, and this inability correlates with the absence of CCR5 expression in these cell types. The ability of SI HIV-1 isolates to infect human primary macrophages has been disputed. Here, we report that CXCR4 is expressed in primary blood-derived human mononuclear phagocytes at all stages of differentiation, although the maturation process correlates with downregulation of CXCR4 mRNA. Infection experiments with the SI molecular clone NL4-3 tagged with a mutant of the green fluorescent protein established that both monocytes and attached macrophages are susceptible to infection with CXCR4-restricted HIV-1 strains. NL4-3 entry into primary macrophages could be blocked by SDF-1alpha in a dose-dependent manner, or by the anti-CXCR4 monoclonal antibody 12G5. HIV-1 entry led to productive infection. No evidence of postentry defects or nuclear import delay for CXCR4-restricted HIV-1 strains was detected using a quantitative real-time PCR assay measuring HIV-1 DNA entry into the nucleus. Macrophages infected by HIV-1 and expressing virus were maintained in culture for long periods of time (up to 5 months). These results demonstrate that CXCR4 is the main HIV-1 SI coreceptor in human primary macrophages and underline the importance of the macrophage as a long-living viral reservoir for HIV-1. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753708     DOI: 10.1006/viro.1999.0136

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes.

Authors:  S Neil; F Martin; Y Ikeda; M Collins
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 2.  Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury.

Authors:  Ricky Maung; Kathryn E Medders; Natalia E Sejbuk; Maya K Desai; Rossella Russo; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-29       Impact factor: 4.147

Review 3.  Type I Interferons in NeuroHIV.

Authors:  Victoria E Thaney; Marcus Kaul
Journal:  Viral Immunol       Date:  2018-09-27       Impact factor: 2.257

4.  Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy.

Authors:  Antonio Valentin; Margherita Rosati; Daniel J Patenaude; Angelos Hatzakis; Leondios G Kostrikis; Marios Lazanas; Kathleen M Wyvill; Robert Yarchoan; George N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

5.  Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load.

Authors:  Leondios G Kostrikis; Giota Touloumi; Rose Karanicolas; Nikos Pantazis; Cleo Anastassopoulou; Anastasia Karafoulidou; James J Goedert; Angelos Hatzakis
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  CCR5 knockout prevents neuronal injury and behavioral impairment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120.

Authors:  Ricky Maung; Melanie M Hoefer; Ana B Sanchez; Natalia E Sejbuk; Kathryn E Medders; Maya K Desai; Irene C Catalan; Cari C Dowling; Cyrus M de Rozieres; Gwenn A Garden; Rossella Russo; Amanda J Roberts; Roy Williams; Marcus Kaul
Journal:  J Immunol       Date:  2014-07-16       Impact factor: 5.422

7.  Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells.

Authors:  Samantha J Willey; Jacqueline D Reeves; Richard Hudson; Koichi Miyake; Nathalie Dejucq; Dominique Schols; Erik De Clercq; Jeanne Bell; Aine McKnight; Paul R Clapham
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons.

Authors:  Katrin Hahn; Barry Robinson; Caroline Anderson; Wenxue Li; Carlos A Pardo; Susan Morgello; David Simpson; Avindra Nath
Journal:  Exp Neurol       Date:  2007-07-06       Impact factor: 5.330

9.  HIV-1 replicates in human osteoclasts and enhances their differentiation in vitro.

Authors:  Jin Gohda; Yijing Ma; Ying Huang; Yu Zhang; Lijun Gu; Yang Han; Taisheng Li; Bin Gao; George Fu Gao; Jun-Ichiro Inoue; Aikichi Iwamoto; Takaomi Ishida
Journal:  Retrovirology       Date:  2015-02-07       Impact factor: 4.602

10.  IFNβ Protects Neurons from Damage in a Murine Model of HIV-1 Associated Brain Injury.

Authors:  Victoria E Thaney; Alan M O'Neill; Melanie M Hoefer; Ricky Maung; Ana B Sanchez; Marcus Kaul
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.